Recent genomic studies have also revealed that a number of somatic alterations (e.g., TP53 and TGFBR2 mutations) may contribute to the maintenance of EBV latency and regulation of the latent-lytic switch in NPC cells (15, 16, 130). The gene discussed is TGFBR2; the disease is nasopharyngeal carcinoma.